共 50 条
- [1] SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: AN INTEGRATED ANALYSISINTERNAL MEDICINE JOURNAL, 2017, 47 : 31 - 31Genovese, M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Palo Alto, CA 94304 USA Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USASmolen, J.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Stanford Univ, Sch Med, Palo Alto, CA 94304 USA论文数: 引用数: h-index:机构:Hyslop, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAMacIas, W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USARooney, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAChen, L.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USADickson, C.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USARiddle, J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USACardillo, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAWinthrop, K.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
- [2] SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: AN INTEGRATED ANALYSISINTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 28Genovese, M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Palo Alto, CA 94304 USA Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USASmolen, J.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Stanford Univ, Sch Med, Palo Alto, CA 94304 USA论文数: 引用数: h-index:机构:Hyslop, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAMacIas, W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USARooney, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAChen, L.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USADickson, C.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USARiddle, J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USACardillo, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USAWinthrop, K.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
- [3] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RA UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSISRHEUMATOLOGY, 2021, 60Winthrop, Kevin L.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USATakeuchi, Tsutomu论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USABurmester, Gerd论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany Free Univ, Berlin, Germany Humboldt Univ, Berlin, Germany Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USADeberdt, Walter论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN 46285 USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USASchlichting, Douglas论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN 46285 USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USAMo, Daojun论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN 46285 USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USAWalls, Chad论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN 46285 USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USASmolen, Josef S.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USA
- [4] Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysisRMD OPEN, 2023, 9 (03):Morand, Eric论文数: 0 引用数: 0 h-index: 0机构: Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaSmolen, Josef S.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaPetri, Michelle论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaTanaka, Yoshiya论文数: 0 引用数: 0 h-index: 0机构: Univ Occupat & Environm Hlth, Kitakyushu, Japan Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaSilk, Maria论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaDickson, Christina论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaMeszaros, Gabriella论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australiade la Torre, Inmaculada论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaIssa, Maher论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaZhang, Hong论文数: 0 引用数: 0 h-index: 0机构: TechData Serv, King Of Prussia, PA USA Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, AustraliaDoerner, Thomas论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany Deutsch Rheumaforsch zentrum, Berlin, Germany Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia
- [5] O09 Safety profile of baricitinib for the treatment of RA up to 8.4 years: an updated integrated safety analysisRHEUMATOLOGY, 2021, 60Winthrop, Kevin L.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USATakeuchi, Tsutomu论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USABurmester, Gerd论文数: 0 引用数: 0 h-index: 0机构: Free Univ, Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany Humboldt Univ, Berlin, Germany Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USADeberdt, Walter论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USASchlichting, Douglas论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USAMo, Daojun论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USAWalls, Chad论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Rheumatol, Indianapolis, IN USA Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USASmolen, Josef S.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR USA
- [6] An Update on the Integrated Safety Analysis of Filgotinib in Patients with Moderately to Severely Active RAARTHRITIS & RHEUMATOLOGY, 2022, 74 : 518 - 521Winthrop, Kevin论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Oregon Hlth & Sci Univ, Portland, OR USA论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Tanaka, Yoshiya论文数: 0 引用数: 0 h-index: 0机构: Univ Occupat & Environm Hlth, Kitakyusyu Fukuoka, Japan Oregon Hlth & Sci Univ, Portland, OR USATakeuchi, Tsutomu论文数: 0 引用数: 0 h-index: 0机构: Keio Univ & Saitama Med Univ, Tokyo, Japan Oregon Hlth & Sci Univ, Portland, OR USAVan Hoek, Paul论文数: 0 引用数: 0 h-index: 0机构: Galapagos NV, Mechelen, Belgium Oregon Hlth & Sci Univ, Portland, OR USAWatson, Christopher论文数: 0 引用数: 0 h-index: 0机构: Galapagos Biotech Ltd, Cambridge, England Oregon Hlth & Sci Univ, Portland, OR USAStiers, Pieter-Jan论文数: 0 引用数: 0 h-index: 0机构: Galapagos NV, Mechelen, Belgium Oregon Hlth & Sci Univ, Portland, OR USARajendran, Vijay论文数: 0 引用数: 0 h-index: 0机构: Galapagos NV, Ghent, Belgium Oregon Hlth & Sci Univ, Portland, OR USAVan Beneden, Katrien论文数: 0 引用数: 0 h-index: 0机构: Galapagos NV, Mechelen, Belgium Oregon Hlth & Sci Univ, Portland, OR USAGottenberg, Jacques-Eric论文数: 0 引用数: 0 h-index: 0机构: Strasbourg Univ Hosp, Strasbourg, France Oregon Hlth & Sci Univ, Portland, OR USABurmester, Gerd论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Berlin, Germany Oregon Hlth & Sci Univ, Portland, OR USA
- [7] AN UPDATED SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RA UP TO 7 YEARSRHEUMATOLOGY, 2020, 59 : 102 - 103Walker, David论文数: 0 引用数: 0 h-index: 0机构: Northumbria Healthcare Trust, NHS, Northumbria, England Northumbria Healthcare Trust, NHS, Northumbria, EnglandKouris, Ilias论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandHolzkamper, Thorsten论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandWu, Marco W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandXavier, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Rio Grande do Sul, Med, Porto Alegre, RS, Brazil Northumbria Healthcare Trust, NHS, Northumbria, EnglandSmolen, Josef论文数: 0 引用数: 0 h-index: 0机构: Dept Med 3, Div Rheumatol, Vienna, Austria Northumbria Healthcare Trust, NHS, Northumbria, EnglandDurez, Patrick论文数: 0 引用数: 0 h-index: 0机构: Clin Univ St Luc, Serv Rhumatol RUMA 5390, Brussels, Belgium Northumbria Healthcare Trust, NHS, Northumbria, EnglandChen, Yi-Hsing论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Tacihung, Taiwan Northumbria Healthcare Trust, NHS, Northumbria, EnglandZhong, Jinglin论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Rockville, MD USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandLiao, Ran论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandGenovese, Mark C.论文数: 0 引用数: 0 h-index: 0机构: Standford Healthcare, Dept Med, Palo Alto, CA USA Northumbria Healthcare Trust, NHS, Northumbria, EnglandWinthrop, Kevin论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Sch Med, Portland, OR USA Northumbria Healthcare Trust, NHS, Northumbria, England
- [8] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSISJCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 133 - 133Genovese, M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USASmolen, J.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USATakeuchi, T.论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAGerd, B.论文数: 0 引用数: 0 h-index: 0机构: Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany Humboldt Univ, Berlin, Germany Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USABrinker, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USARooney, T.论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Durham, NC USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAZhong, J.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAMo, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USASaifan, C.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USACardoso, A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAIssas, M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAWu, W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAWinthrop, K.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USAGomez-Martin, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly Mexico, Mexico City, DF, Mexico Stanford Univ, Div Immunol & Rheumatol, Stanford, CA 94305 USA
- [9] SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 5.5 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSISJCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S83 - S83Genovese, M. C.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USASmolen, J. S.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA论文数: 引用数: h-index:机构:Hyslop, D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USAMacias, W. L.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USARooney, T. P.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USAChen, L.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USADickson, C. L.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USACamp, J. R.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USACardillo, T. E.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USAIshii, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Kobe, Hyogo, Japan Stanford Univ, Med Ctr, Palo Alto, CA 94304 USAWinthrop, K. L.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USAGarcia, E. G.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
- [10] Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 7 Years: An Updated Integrated Safety AnalysisARTHRITIS & RHEUMATOLOGY, 2019, 71Genovese, Mark论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USA Stanford Univ, Stanford, CA 94305 USASmolen, Josef论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Vienna, Austria Stanford Univ, Stanford, CA 94305 USATakeuchi, Tsutomu论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Sch Med, Tokyo, Japan Stanford Univ, Stanford, CA 94305 USABurmester, Gerd论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Berlin, Germany Stanford Univ, Stanford, CA 94305 USABrinker, Dennis论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USARooney, Terence论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USAZhong, Jinglin论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Morrisville, NC USA Stanford Univ, Stanford, CA 94305 USAMo, Daojun论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USASaifan, Chadi论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USACardoso, Anabela论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USAIssa, Maher论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USAWu, Wen-Shuo论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Stanford Univ, Stanford, CA 94305 USAWinthrop, Kevin论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Portland, OR 97201 USA Stanford Univ, Stanford, CA 94305 USA